骨髓中的内皮异质性:跨发展,成年生活和白血病的见解
I L Boueya1, L Sandhow1, J R P Albuquerque1
1Leukemia and Niche Dynamics laboratory, Institut Cochin, Université Paris Cité UMR-S1016, INSERM U1016, CNRS UMR8104, Paris, France.
Leukemia
|November 11, 2024
概括
骨髓血管表现出显著的异质性,这对血液细胞的产生和整体健康至关重要. 了解这些内皮细胞差异有助于治疗白血病等疾病.
科学领域:
- 血液学 血液学 血液学
- 血管生物学 血管生物学
- 细胞微环境 细胞微环境
背景情况:
- 骨髓 (BM) 微环境,特别是其血管系统,对于维持血细胞的生产和稳态至关重要.
- 在BM血管系统中的内皮细胞表现出显著的结构和功能异质性,这是最近引起关注的概念.
研究的目的:
- 审查最近在不同生命阶段的BM微环境中了解内皮细胞异质性的进展.
- 探索白血病对BM血管异质性的影响及其对临床实践的影响.
主要方法:
- 对BM血管和内皮细胞生物学现有文献的综合.
- 审查单细胞方法和先进的微观观测.
- 分析正常与病理状况中的表型差异.
主要成果:
- 最近的进展揭示了与BM内的特定解剖位置相关的多种内皮细胞状态.
- 内皮细胞的表型变异在健康和疾病状态中都被观察到,影响血液形成.
- 白血病显著改变BM血管异质性.
结论:
- 内皮细胞异质性是BM功能和血液形成的关键因素.
- 了解这些血管动态为改善血液病的临床结果提供了潜在的治疗点.
- 需要进一步的研究,以充分阐明有关BM血管异质性的尚未解决的问题.
相关概念视频
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Overview of Hematopoiesis
3.8K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.8K
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


